NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

TITAN BIOTECH

BSE: 524717 22 Feb 2025
Commodities
₹ 434.0
Titan Bio-Tech Ltd. specializes in Specialty Chemicals within the Commodities sector.

TITAN BIOTECH - Share Price & Details

Market Cap
₹358.0
High /Low
1,018 / 423.0
Stock P/E
15.9
Book Value
₹175.0
Dividend Yield
0.46
ROCE
25.1
ROE
₹20.4
Face Value
10.0
PEG Ratio
0.34
EVEBITDA
₹11.3
Debt
2.61
CMP / FCF
37.5
Debt to equity
₹0.02
NP Ann
24.8
High price all time
1,018
Piotroski score
₹6.0
Graham Number
328.0
No. Eq. Shares
0.83
Net CF
₹-2.02
Net profit
22.5
Price to book value
2.47
Interest Coverage
₹25.0
Low price all time
8.57
Industry PE
28.8
Reserves
₹137
Free Cash Flow
₹12.4

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Southern Gas Ltd.,90.44166.980.03
Indo Gulf Industries Ltd.,611.192.37
TITAN BIOTECH LTD.382.765.3115.9
RUCHIRA PAPERS LTD.1,678.755.526.04
MULTIBASE INDIA LTD.171.481.8824.3

Peer Comparison Chart


About TITAN BIOTECH

Titan Bio-Tech Ltd., with Security Code 524717, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Latest News

Sinovac Biotech's Board Dispute Resolved: Privy Council Confirms 2018 Shareholder Nominees

(16 Jan 2025)
Sinovac Biotech (NASDAQ:SVA) announced that the Judicial Committee of the Privy Council in London has made two significant rulings: first,...
Read more →

Manish Goel recommends three multi-bagger stocks for long term | Stock Market News

(10 Jan 2025)
Indian stock markets are currently under pressure, primarily due to significant selling by foreign institutional investors (FIIs).
Read more →

Clinical Trials News Live Feed

(20 Dec 2024)
Access real-time updates on biotech clinical trials and their market impact. Our live feed delivers key insights on drug development...
Read more →

ImmunoPrecise Antibodies to Present at Microcap Conference 2025: AI-Driven Biotech Showcase

(19 Dec 2024)
ImmunoPrecise Antibodies (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has announced its participation in The...
Read more →

EUDA Health Eyes Major Stem Cell Therapy Expansion Through Guangdong Cell Biotech Partnership Talks

(17 Dec 2024)
EUDA Health explores strategic partnership with Guangdong Cell Biotech to integrate stem cell therapies into its digital healthcare platform...
Read more →

Portage Biotech Advances Strategic Deal with Immunova for Promising Cancer Therapy Portfolio

(17 Dec 2024)
Portage Biotech (NASDAQ: PRTG) has entered into a Letter of Intent (LOI) with Immunova, a private Connecticut-based biotechnology company,...
Read more →